Back to Fort Fairfield Journal WFFJ-TV Contact Us
In Norway, 29 Dead After Receiving COVID-19 Vaccine
24 Dead in New York Nursing Home
After Receiving COVID-19 Vaccine
Miami, Florida Doctor Also Dies After COVID-19 Jab
By: David Deschesne
Fort Fairfield Journal, January 27, 2021
Health officials from Norway report 23 deaths of nursing home residents shortly after receiving the Pfizer COVID-19 vaccine, a few days later, they revised that number to 29.1
The Norwegian Medicines Agency told the British Medical Journal2 the agency has investigated 13 deaths as of January 15 and concluded common adverse reactions of mRNA vaccines, such as fever, nausea and diarrhea may have contributed to fatal outcomes in some of the frail patients.
In the Commons on St. Anthony Nursing Home in New York, 24 residents reportedly died after they began receiving COVID-19 vaccines on December 22.
As U.S. presidential impersonator, Joe Biden pushes for 100 million Americans to be vaccinated for COVID-19 in 100 days, recipients of the COVID-19 vaccine are dropping like flies worldwide as the establishment media remains silent on the damage the experimental vaccines, produced at recklessly rapid speed, are causing.
In Miami, Florida, Dr. Gregory Michael, 56, died 16 days after being vaccinated with the Pfizer vaccine. His wife said three days after he was vaccinated, he saw severe broken vessels on his feet and hands and was diagnosed with immune thrombocytopenia, which prevents blood from clotting due to abnormally low levels of platelets. He went to the emergency room and two weeks later died within moments after suffering a hemorrhagic stroke. His wife said she believes his death was “100% linked to the vaccine.”
The CDC continues to endorse the COVID-19 vaccines, which are still in the experimental stage with tests now being conducted on large populations of humans, said side effects tend to be “mild to moderate and go away quickly.” Of course, a patient’s death is one way for those side effects to “go away quickly.”
It continues to get worse for President Trump’s “Warp Speed” vaccine production program as a vaccination super station in San Diego, California was forced to stop using a particular lot of Moderna’s RNA vaccine due to an “unusually high number” of adverse reactions. San Diego County reported that allergic reactions were detected in six vaccine recipients and the center was closed for several hours.
The COVID-19 vaccine is a radically new technology that has never been used in humans before. These vaccines were produced at “warp speed” with no animal trials and scant human trials only to determine if they produce antibodies. The last time a mRNA vaccine was tried was in 2002 for China’s SARS COV outbreak. While the animals in that trial developed antibodies, they ended up suffering debilitating immune responses and death when exposed to the naturally occurring coronaviruses.
mRNA vaccines work by genetically modifying a human’s cells to create parts of COVID-19 within them, much the same way corn is genetically modified to produce insecticide inside the corn kernels to kill bugs. While the vaccines are functionally gene therapy and not a real vaccine, they’re being called “vaccines” so they can qualify for the 1986 U.S. law that limits liability for wrongful death and other health damages caused by vaccines.
Neither Pfizer nor Moderna claim their products create immunity to COVID-19 but that they may simply “lesson the symptoms.” The New England Journal of Medicine and the Lancet reported that “no correlate of protection from SARS-CoV-2 has been established,” which means there is no evidence the vaccines protect against anything.
A US CDC document entitled Anaphylaxis Following m-RNA COVID-19 Vaccine Receipt published on December 19, 2020 showed out of a total of 112,807 people who received a COVID-19 vaccine, 3,150 of that group suffered side effects significant enough that they were “unable to perform normal daily activities, unable to work, required care form doctor or other health care professional.”3
Notes:
2. https://www.bmj.com/content/372/bmj.n149